Pulse Biosciences, Inc.
PLSE
Ранг среди акций
#4267
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Цена акции
$51.39
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$3.67B
Изменение (1 день)
1.09%
Изменение (1 год)
197.94%
Страна
US
Торговля Pulse Biosciences, Inc. (PLSE)
Категория
Healthcare
Коэффициент P/B для Pulse Biosciences, Inc. (PLSE)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Pulse Biosciences, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Pulse Biosciences, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 8.1997 | - |
US
|
|
| 1.7417 | - |
FR
|
|
| - | - |
JP
|
|
| 2.1258 | - |
US
|
|
| - | - |
CH
|
